Here, we identified USP12 as a deubiquitinase broadly downregulated in NSCLC and showed that convergent AKT-mTOR activation downstream of the oncogenic mutations was responsible for the inhibited expression of USP12. This evidence concerns the gene MTOR and non-small cell lung carcinoma.